pregnant women
Feb 26, 2025
Authors:Â Bertagnolli L, Deng Z, Davy-Rothwell M, Abrams EJ, Flexner C, Weld ED. Abstract: Background/Objectives:Â Long-acting and extended-release drug delivery strategies have greatly improved treatment for a variety of medical conditions. Special populations,...
Mar 31, 2023
Authors:Â Kirsty Brittain, Yolanda Gomba, Sandisiwe Noholoza, Jennifer Pellowski, Claude A Mellins, Linda-Gail Bekker, Ashraf Kagee, Robert H Remien, Elaine J Abrams, Landon Myer Abstract:Â Young pregnant and postpartum women living with HIV (WLHIV) are at high risk...
Feb 23, 2023
Authors: Martina Penazzato, Ivy Kasirye, Theodore Ruel, Irene Mukui, Adrie Bekker, Mohendran Archary, Philippa Musoke, Shaffiq Essajee, George K Siberry, Mary Mahy, Daniele Simnoue, Beatriz Simione, Jennifer M Zech, Angela Mushavi, Elaine J Abrams, PNP meeting...
Jan 24, 2023
Authors: Steven P Masiano, Tapiwa A Tembo, Xiaoying Yu, Elizabeth Wetzel, Mtisunge Mphande, Mike Chitani,  Angella Mkandawire, Innocent Khama, Alick Mazenga, Elaine Abrams, Saeed Ahmed, Maria H Kim Abstract: Background: Intimate partner violence (IPV) is associated...
Aug 10, 2022
Abstract: In 2021, long-acting cabotegravir (LA CAB) was approved by the United States Food and Drug Administration for an indication of pre-exposure prophylaxis in women. This is a first in what is hoped to be a robust pipeline of long-acting antiretroviral agents...